The Evidence on Ozempic to Treat Addiction

The New Yorker The New Yorker

Dhruv Khullar on the latest research on GLP-1 drugs, which, though typically used to manage diabetes and obesity, are showing promise as groundbreaking treatments for addictions of all kinds.

Read full article at The New Yorker →